Stay updated on ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Sign up to get notified when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.

Latest updates to the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page
- ChecktodayChange DetectedNo additions or deletions were provided to assess changes for this page.SummaryDifference0.1%

- Check8 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the page's revision history. This update records a metadata change that does not affect study data, content, or navigation.SummaryDifference0.1%

- Check15 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check43 days agoChange DetectedBeta-thalassemia major keyword was added and the page revision updated to v3.4.2; the government funding lapse notice (revision v3.4.1) was removed.SummaryDifference0.5%

- Check50 days agoChange DetectedAdded a government funding lapse notice with guidance to check status at cc.nih.gov and opm.gov; updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check58 days agoChange DetectedUI updates include a new Show glossary option, and label changes such as 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'. Additionally, a new revision note 'Revision: v3.4.0' was added and the old labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

Stay in the know with updates to ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ST-400 for TDT: Safety, Tolerability, and Efficacy Clinical Trial page.